OR WAIT null SECS
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
June 25, 2010
Teva Pharmaceuticals in the US has admitted to including false statements in the physician prescribing information for its oral contraceptive product Gianvi, a generic version of Bayer Healthcare?s YAZ oral contraceptive.
A new dialogue between governments and the pharma industry is being called for by Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA, to address access to and affordability of European medicines, as well as Europe?s competitiveness as a base for R&D investment.
European pharmaceutical companies are outdoing their US counterparts when it comes to making medicines available to developing countries, according to the Access to Medicine Index, which analyses and ranks the access to medicine efforts of the world?s largest pharma companies.
June 24, 2010
A new dialogue between governments and the pharma industry is being called for by Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA, to address access to and affordability of European medicines, as well as Europe's competitiveness as a base for R&D investment.
European pharmaceutical companies are outdoing their US counterparts when it comes to making medicines available to developing countries, according to the Access to Medicine Index, which analyzes and ranks the access to medicine efforts of the world's largest pharma companies.
June 18, 2010
A new form of study for assessing the benefits and risks of medicines has been launched in the EU with the hope of increasing public trust in study findings.